SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CELL THERAPEUTICS
(NQSC:CTIC Last Sale: 1.09 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (CTIC : $1.09)
$183 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
201 Elliott Ave W Research Report World View
Ste 400 Fact Sheet Earnings Snapshot - Last 10/29/18
Seattle, WA 98119 Financial Statements
Phone: (206) 282-7100 Peer Comparison
Fax: (206) 213-8317 Annual Reports

Philip M. Nudelman, Chmn., James A. Bianco, Pres./CEO, Louis A. Bianco, CFO
Researches, develops and markets small molecule drugs for the treatment of cancer and inflammatory and immune dieases. IPO at $10 March 20, 1997. Raised $30 MM, selling 3 MM shares, 23% of the outstanding. Lead Manager: UBS Securities. Licensing deal worth up to $285 million with Novartis for Xyotax, a cancer drug in clinical trials, announced September 18, 2006. Secondary sold 23.1 million shares at $1.73 September 19, 2006. Completed the $30 million purchase of Biogen Idec's (BIIB) cancer drug Zevalin December 27, 2007.
Historical Charts    Technical Analysis
No Historical Data available for CTIC

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CTIC $1.09 $ 0 $1.09 $1.12 602,778 $.97 $3.939 167,568
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $182,649

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
13-JUN-11 CTICD Symbol Changed to CTIC
17-MAY-11 CTIC Symbol Changed to CTICD
16-MAY-11 CTIC Split 1 for 6
14-MAY-07 CTICD Symbol Changed to CTIC
16-APR-07 CTIC Symbol Changed to CTICD
13-APR-07 CTIC Split 1 for 4

A105
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex